Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach.
Journal:
BMC pulmonary medicine
PMID:
32013930
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is combination of progressive lung diseases. The diagnosis of COPD is generally based on the pulmonary function testing, however, difficulties underlie in prognosis of smokers or early stage of COPD patients due to the complexity and heterogeneity of the pathogenesis. Computational analyses of omics technologies are expected as one of the solutions to resolve such complexities.